Head-to-Head: which lupus drug works better?

This study compares two drugs, telitacicept and belimumab, for controlling systemic lupus erythematosus (SLE) in adults aged 18-65. Participants choose their treatment with their doctor, and researchers track how well each drug reduces lupus activity and kidney problems. The goal is to see which option is more effective and safer for managing this chronic autoimmune disease.